Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2003 1
2007 2
2011 2
2012 4
2014 1
2015 5
2016 8
2017 5
2018 2
2019 7
2020 9
2021 8
2022 8
2023 9
2024 6

Text availability

Article attribute

Article type

Publication date

Search Results

71 results

Results by year

Filters applied: . Clear all
Page 1
Exploring the optimal indicator of short-term peridiagnosis weight dynamics to predict cancer survival: A multicentre cohort study.
Yin L, Zhang L, Li L, Liu M, Zheng J, Xu A, Lyu Q, Feng Y, Guo Z, Ma H, Li J, Chen Z, Wang H, Li Z, Zhou C, Gao X, Weng M, Yao Q, Li W, Li T, Shi H, Xu H. Yin L, et al. Among authors: ma h. J Cachexia Sarcopenia Muscle. 2024 Apr 21. doi: 10.1002/jcsm.13467. Online ahead of print. J Cachexia Sarcopenia Muscle. 2024. PMID: 38644549 Free article.
Ex Vivo Optimization of Donor Lungs with Inhaled Sevoflurane during Normothermic Ex Vivo Lung Perfusion (VITALISE): A Pilot and Feasibility Study in Sheep.
Steinkühler T, Yang S, Hu MA, Jainandunsing JS, Jager NM, Erasmus ME, Struys MMRF, Bosch DJ, van Meurs M, Jabaudon M, Richard D, Timens W, Leuvenink HGD, Nieuwenhuijs-Moeke GJ. Steinkühler T, et al. Among authors: hu ma. Int J Mol Sci. 2024 Feb 19;25(4):2413. doi: 10.3390/ijms25042413. Int J Mol Sci. 2024. PMID: 38397090 Free PMC article.
TCCIA: a comprehensive resource for exploring CircRNA in cancer immunotherapy.
Wang S, Xiong Y, Zhang Y, Wang H, Chen M, Li J, Luo P, Luo YH, Hecht M, Frey B, Gaipl U, Li X, Zhao Q, Ma H, Zhou JG. Wang S, et al. Among authors: ma h. J Immunother Cancer. 2024 Jan 11;12(1):e008040. doi: 10.1136/jitc-2023-008040. J Immunother Cancer. 2024. PMID: 38212124 Free PMC article.
Effects of ketone body 3-hydroxybutyrate on cardiac and mitochondrial function during donation after circulatory death heart transplantation.
Seefeldt JM, Libai Y, Berg K, Jespersen NR, Lassen TR, Dalsgaard FF, Ryhammer P, Pedersen M, Ilkjaer LB, Hu MA, Erasmus ME, Nielsen RR, Bøtker HE, Caspi O, Eiskjær H, Moeslund N. Seefeldt JM, et al. Among authors: hu ma. Sci Rep. 2024 Jan 8;14(1):757. doi: 10.1038/s41598-024-51387-y. Sci Rep. 2024. PMID: 38191915 Free PMC article.
Nimotuzumab plus concurrent chemo-radiotherapy in unresectable locally advanced oesophageal squamous cell carcinoma (ESCC): interim analysis from a Phase 3 clinical trial.
Meng X, Zheng A, Wang J, Wu X, Li G, Zhu J, Ma H, Zhu X, Shi A, Dai C, Yan S, Wang B, Qu Z, Han C, Sun X, Ye M, Fan R, Huerxidan N, Wang X, Yu J. Meng X, et al. Among authors: ma h. Br J Cancer. 2023 Nov;129(11):1787-1792. doi: 10.1038/s41416-023-02388-7. Epub 2023 Oct 20. Br J Cancer. 2023. PMID: 37864049 Clinical Trial.
Identification of an endogenous retroviral signature to predict anti-PD1 response in advanced clear cell renal cell carcinoma: an integrated analysis of three clinical trials.
Zhou JG, Zeng Y, Wang H, Jin SH, Wang YJ, He S, Frey B, Fietkau R, Hecht M, Ma H, Zhang W, Gaipl US. Zhou JG, et al. Among authors: ma h. Ther Adv Med Oncol. 2022 Sep 24;14:17588359221126154. doi: 10.1177/17588359221126154. eCollection 2022. Ther Adv Med Oncol. 2022. PMID: 37614979 Free PMC article.
71 results